The Health Blog

It is unfortunately true that those with epilepsy do encounter a fair amount of prejudice against them, especially in the field of employment. This prejudice is perhaps based on dimly held knowledge of those in special care, or institutions, with the very worst epilepsy, often in association with mental retardation due to major neurological disease.

Prejudice against those with other illnesses is rare. No one minds if you have only one kidney or varicose veins. Most people go out of their way to help a blind person, or someone in a wheelchair. However, a blind or physically disabled person is immediately perceived as ‘different’. Bystanders can make judgements about his abilities. They may relate to him in a special way—a manner which is instantly perceived and resented by an occupant of the wheelchair! Such a visible handicap is perceived and managed as such by society. Someone with epilepsy, however, is perfectly normal for 99.9 per cent of the time. His ‘handicap’ is invisible. He then discredits himself, as it were, by having a seizure. His acquaintances feel deceived. The man they thought was a bank manager turns out to be ‘really an epileptic’, passing himself off as normal. Such an attitude is ridiculous, yet there is persistent evidence for it. Such prejudice will, we hope, gradually fade, as misconceptions about epilepsy are dispelled. However, it would be foolish to deny its existence at the present time.

A major problem that someone with epilepsy has to decide, therefore, is how much to tell, and to whom. For example, no mother wants to tell everyone that her son has epilepsy, but if the boy is staying the night at the house of a friend, it is only sensible to let his friend’s parents know that he might have a seizure, and to tell them how to cope. Most parents would agree with this policy if the boy was having seizures every fortnight or so—but what if they occurred only every six months? Parents might feel that they were spoiling the boy’s chances of friendship and social development if they sent him off with the label of epilepsy around his neck.

Young people with epilepsy forming friendships with the opposite sex also suffer agonies about these decisions. If the epilepsy is not talked about early in the relationship the subject becomes more and more difficult to bring up. The problem may then be revealed by the occurrence of a seizure without prior explanation. Both parties feel devastated—the one guilty and ashamed at not having had the courage to explain the problem, the other surprised and ashamed of their surprise and inability to cope both with the seizure and their own feelings about it.

On balance, we are sure that it is best for a person with epilepsy to tell those he meets frequently something of the facts, so that they can cope if a seizure occurs. Friends will appreciate the confidence shown in them by the fact of this disclosure.

*78\188\2*

We’ve had the joy of knowing that over 100,000 arthritis sufferers have substantially benefited by taking certified CMO in its various approved formulations. CMO is often combined with other nutritional substances that contribute additional benefits to its healing effects, such as sea cucumber, DL-phenylalanine, and glucosamine sulphate.

First of all, the success rates of curing arthritis and other disorders using CMO continue to be astonishing. One authorized distributor of certified CMO reports a 96% customer satisfaction rate. This high level of customer satisfaction duplicates the success rate of the original study conducted by the San Diego Clinic (now renamed San Diego International Immunological Center after considerable expansion of its research efforts). Since the purpose of the original study was to determine the beneficial health effects of CMO only on arthritis, subjects with only arthritis as their sole medical complaint were accepted for the study. Additionally, individuals who had been or were currently taking potent immunosuppressants, including high doses of steroids, were also deemed to be unsuitable as subjects. This pre-selection is normal practice in medical trials. No one expected the success rates of CMO formulations for the general public use to be more than about 70%, especially as people would be taking CMO without the benefit of clinical supervision. Yet, remarkably, success rates in the field have almost always exceeded our expectation.

The clinic’s research and the practical experiences of working with thousands of patients has revealed a great deal more about arthritis and other autoimmune diseases than was previously known. We have also discovered much about the arthritic and autoimmune processes from our own continuing research, as well as the research of my colleagues. This new knowledge has prompted expansion of some of my approaches to CMO treatment programs.

When we began our CMO research, we did so with the intent of attaining remission against the autoimmune processes of arthritis. That was our focus. However it was not long after CMO was being utilized by physicians and other medical professionals in their practices, that I began receiving reports of various benefits for many other autoimmune and chronic inflammatory conditions. It was only then that I realized that CMO was a universal-autoimmune immunomodulator. That is what launched new research that led to a more complete understanding of memory T-cell function and how the autoimmune processes cause a variety of degenerative diseases. (See Chapter 1 for information on memory T-cell function.)

Although CMO routinely succeeds in affecting a person’s entire memory T-cell population, and halting the destructive autoimmune disease process, I still found a number of patients whose symptoms began to return after some length of time. Sometimes it was just a matter of a few weeks or a few months, and sometimes it took a year or more.

The excepts from the following letter illustrate these types of recurrences:

Dear Dr. Sands,

Thanks so much for the articles and testimonials. I am a true believer myself because it worked so well for me. I can’t thank you enough for agreeing to make this injectable [CMO] for me and my friend. It means a lot.

Again thank you from the bottom of my heart. CMO has really saved my life. I didn’t think I could ever live free of pain, but CMO changed all that and more. I don’t take Prozac any longer, nor do I take Advil [up to 10 a day before]…

I think your other research is really fascinating. I used to think I had Parkinson’s or MS or something because I would shake so much, but Prozac fixed that. And CMO fixed whatever it was permanently so I don’t need Prozac.

I do need tune-ups, about every 3-4 months or when I go through a stressful period. But CMO takes care of whatever is wrong. I can’t say enough about how great it is, and I can’t thank you enough for taking the time to pursue CMO to a point where it’s available to all people.

Thanks again. May God bless you in every way,

Micky C, Colorado

My new research and understanding of how easily and frequently autoimmune processes are started, lead me to the explanation of these recurrences. Virtually any infection, trauma, disease, or environmental factor can trigger an autoimmune response. We are faced with these exposure events nearly every day. Often the body deals with these events in an effective manner that does not trigger a destructive autoimmune process. Sometimes a new autoimmune response is triggered and simply withers away. Sometimes it lingers and goes unnoticed, but then it almost always develops into a troublesome or crippling ailment. This process may happen quickly or it may take months or years before it develops tormenting symptoms.

These autoimmune hiccups abound in our modern environment so often that it has prompted me to develop what I consider to be a very valuable maintenance and preventive treatment program. Since CMO has now proved to be a universal-immunomodulator, this new program should prove effective against a very large number of ailments with autoimmune factors. Such ailments include fibromyalgia, lupus, sarcoidosis, scleroderma, multiple sclerosis, emphysema, asthma, some allergies, prostatitis, juvenile diabetes, diabetes, psoriasis, macular degeneration, tendinitis, sciatica, and others – as well as all forms of arthritis.

But before I explain this new CMO preventive/maintenance program, let’s have a look at some of the substances involved. I have found sea cucumber, DLPA, and glucosamine to be particularly beneficial and completely compatible with using CMO.

*94\142\2*

Signs and symptoms

The burrowing of the insects and the skin’s allergic reaction to their presence cause relentless itching. When the child scratches to relieve the itching, secondary infection can set in.

The diagnosis is based on the appearance and location on the skin of the small, red dots that mark the openings to the mites’ burrows. The diagnosis also is suggested by gray or black lines on the skin marking the insects’ tunnels. However, these signs on the skin can be obscured quickly by scratching.

Home care

Mites can be destroyed by applying a lindane ointment or lotion or an ointment or lotion containing benzene hexachloride or crotonyl-N-ethyl-o-toluide. Before you use these medications, discuss them with your doctor. The medication is applied to all skin surfaces except the head and the face. If your infant appears to have scabies on the face consult your doctor before applying any medication. Because scabies is so easily transmitted from person to person, all family members should receive treatment at the same time. Treatment can be repeated once or twice. Nonprescription antihistamines may be used for temporary relief of itching.

Precautions

•     If marks on the skin and itching continue after treatment, the infected person may have been re-infested, or may have a persistent allergic reaction or secondary infection. Do not keep treating the condition in the hope that it will clear up; see your doctor.

•     Destroy mites on undergarments, bedding, and towels by laundering these items.

•     Lindane ointment or lotion is poisonous; be sure to keep it out of the reach of children.

Medical treatment

Your doctor will prescribe oral antibiotics to treat a secondary infection and antihistamines to relieve an allergic reaction.

*180/84/5*